EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin

Yasuharu Yamada iD, Junzo Iemura, Atushi Kambara, Noboru Tateishi, Yuji Kozaki, Masako Yamada, Junko Maruyama, Eiichi Azuma

The Journal of ExtraCorporeal Technology · 2023

DOI: 10.1051/ject/2023003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of ExtraCorporeal Technology, 2023. Verfasst von Yasuharu Yamada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science Mie 513-8670 Japan. Hauptthemen laut MEDLINE: Heparin, Atrial Fibrillation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative atrial fibrillation (POAF) is defined as new-onset AF in the immediate postoperative period. The relatively high incidence of POAF after cardiac surgery is well described, but pathophysiological mechanisms underlying the initiation, maintenance, and progression of POAF may be multifactorial and have not yet been comprehensively characterized. One of the mechanisms includes altered Ca 2+ kinetics. Accumulating evidence has suggested that altered atrial cytosolic calcium handling contributes to the development of POAF, protamine reversibly modulates the calcium release channel/ryanodine receptor 2 (RyR2) and voltage-dependent cardiac RyR2. However, it is currently unknown whether such abnormalities contribute to the arrhythmogenic substrate predisposing patients to the development of POAF.

Methods

We have retrospectively analyzed 147 patients who underwent cardiac surgery with cardiopulmonary bypass support. Of these, 40 patients were excluded from the analysis because of pre-existing AF. All patients received heparin followed by protamine at different dosing ratios of protamine-to-heparin, depending on the periods studied.

Results

The dosing ratio of protamine-to-heparin = 1.0 was compared with higher dosing ratios of protamine-to-heparin >1.0 up to 1.7. POAF developed in 15 patients (15/107 = 14%), of these, 5 out of 57 patients (33.3%) in the dosing ratio of protamine-to-heparin = 1.0 and 10 out of 35 patients (66.7%) in the higher dosing ratios of protamine-to-heparin. Statistical significance was observed in patients with higher dosing ratios of protamine-to-heparin, compared with the dosing ratio of protamine-to-heparin = 1.0 (odds ratio = 3.890, 95% CI = 1.130–13.300, p -value = 0.031). When types of diseases were analyzed in terms of higher dosing ratios of protamine-to-heparin, only valvular disorders were significantly associated with POAF ( p = 0.04).

Conclusions

Protamine is clinically utilized to reverse heparin overdose and has been shown to display immunological and inflammatory alterations. However, its association with POAF has not been reported. Our results provide evidence that higher dosing ratios of protamine-to-heparin may increase the incidence of POAF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinAtrial FibrillationHumansProtaminesCoronary Artery BypassRetrospective StudiesCalciumRyanodine Receptor Calcium Release ChannelPostoperative PeriodPostoperative ComplicationsRisk Factors

Stichwörter der Autor:innen

AnticoagulationCalciumCardiopulmonary bypassPostoperative atrial fibrillation (POAF)Protamine-to-heparin ratio

Substanzen

HeparinProtaminesCalciumRyanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science Mie 513-8670 Japan.
  • Department of Cardiovascular Surgery, Okanami General Hospital Mie 518-0121 Japan.
  • Division of Clinical Engineering, Okanami General Hospital Mie 518-0121 Japan.
  • Department of Clinical Engineering, Mie University Hospital Mie 514-0001 Japan.

ORCID-Profile: Yasuharu Yamada

Zitieren

APA

Yamada, Y., Iemura, J., Kambara, A., Tateishi, N., Kozaki, Y., Yamada, M., Maruyama, J., & Azuma, E. (2023). Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin. The Journal of ExtraCorporeal Technology. https://doi.org/10.1051/ject/2023003

Vancouver

Yamada Y, Iemura J, Kambara A, Tateishi N, Kozaki Y, Yamada M, et al. Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin. The Journal of ExtraCorporeal Technology. 2023. doi:10.1051/ject/2023003

BibTeX
@article{Yamada2023,
  author = {Yamada, Yasuharu and Iemura, Junzo and Kambara, Atushi and Tateishi, Noboru and Kozaki, Yuji and Yamada, Masako and Maruyama, Junko and Azuma, Eiichi},
  title = {Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin},
  journal = {The Journal of ExtraCorporeal Technology},
  year = {2023},
  doi = {10.1051/ject/2023003}
}
Kostenlos starten →